Effects of Angiotensin II Receptor Blockade and Angiotensin Converting Enzyme Inhibitor on Ventricular Remodeling After Myocardial Infarction: With Special References to Sarcoplasmic Reticulum and its mRNA

Ventricular Remodeling ◽

Enzyme Inhibitor ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Effect of angiotensin II receptor blockade, candesartan, on the ventricular remodeling after myocardial infarction: comparison with angiotensin converting enzyme inhibitor

Journal of Cardiac Failure ◽

10.1016/s1071-9164(03)00535-9 ◽

2003 ◽

Vol 9 (5) ◽

pp. S62

Author(s):

Eiichi Geshi ◽

Hiroshi Suzuki ◽

Takatoshi Sato ◽

Makoto Shoji ◽

Yoshitaka Iso ◽

...

Keyword(s):

Myocardial Infarction ◽

Angiotensin Ii ◽

Ventricular Remodeling ◽

Enzyme Inhibitor ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse

Clinical Science ◽

10.1042/cs20020219 ◽

2003 ◽

Vol 104 (2) ◽

pp. 109 ◽

Cited By ~ 11

Author(s):

Richard D. PATTEN ◽

Mark J. ARONOVITZ ◽

Michael EINSTEIN ◽

Matthew LAMBERT ◽

Natesa G. PANDIAN ◽

...

Keyword(s):

Myocardial Infarction ◽

Angiotensin Ii ◽

Receptor Blockade ◽

Converting Enzyme ◽

Ventricular Remodelling ◽

Angiotensin Ii Receptor ◽

Gene Expression Profile Revealed Different Effects of Angiotensin II Receptor Blockade and Angiotensin-Converting Enzyme Inhibitor on Heart Failure

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-200312001-00002 ◽

2003 ◽

Vol 42 ◽

pp. S1-S6 ◽

Cited By ~ 2

Author(s):

Miho Mizukami ◽

Hiroshi Hasegawa ◽

Takahide Kohro ◽

Haruhiro Toko ◽

Sumiyo Kudoh ◽

...

Keyword(s):

Gene Expression ◽

Heart Failure ◽

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade

Journal of Human Hypertension ◽

10.1038/sj.jhh.1002101 ◽

2006 ◽

Vol 21 (1) ◽

pp. 20-27 ◽

Cited By ~ 136

Author(s):

P Dandona ◽

S Dhindsa ◽

H Ghanim ◽

A Chaudhuri

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Tu-P7:247 Angiotensin-converting enzyme inhibition reduces the activity of MMP while angiotensin II receptor blockade inhibits the MMP expression and activity

Atherosclerosis Supplements ◽

10.1016/s1567-5688(06)80951-7 ◽

2006 ◽

Vol 7 (3) ◽

pp. 239

Author(s):

H. Kurata ◽

N. Machida ◽

C. Yanagisawa ◽

Y. Kishimoto ◽

M. Hasegawa ◽

...

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Blockade ◽

Expression And Activity

Benefit of Combining Maximal Angiotensin-Converting Enzyme Inhibition with Angiotensin II Receptor Blockade

Cardiology in Review ◽

10.1097/00045415-199907000-00005 ◽

1999 ◽

Vol 7 (4) ◽

pp. 169

Author(s):

&NA;

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Angiotensin II-Receptor Blockade Further Reduces Afterload Safely in Patients Maximally Treated with Angiotensin-Converting Enzyme Inhibitors for Heart Failure

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199710000-00020 ◽

1997 ◽

Vol 30 (4) ◽

pp. 533-536 ◽

Cited By ~ 38

Author(s):

Glenn Hamroff ◽

Ira Blaufarb ◽

Donna Mancini ◽

Stuart D. Katz ◽

Rachel Bijou ◽

...

Keyword(s):

Heart Failure ◽

Angiotensin Ii ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Faculty Opinions recommendation of Comparison of 5-year survival after acute myocardial infarction using angiotensin-converting enzyme inhibitor versus angiotensin II receptor blocker.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718472616.793506371 ◽

2015 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Angiotensin Ii Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitor

Effects of Valsartan, an Angiotensin II Receptor Blocker, on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction Who Receive an Angiotensin-Converting Enzyme Inhibitor

Circulation Journal ◽

10.1253/circj.cj-11-1102 ◽

2012 ◽

Vol 76 (6) ◽

pp. 1442-1451 ◽

Cited By ~ 9

Author(s):

Hideto Yano ◽

Kiyoshi Hibi ◽

Naoki Nozawa ◽

Hiroyuki Ozaki ◽

Ikuyoshi Kusama ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Angiotensin Ii ◽

Coronary Atherosclerosis ◽

Enzyme Inhibitor ◽

Angiotensin Ii Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Ii Receptor

Angiotensin-Converting Enzyme Inhibition but not Angiotensin II Receptor Blockade Regulates Matrix Metalloproteinase Activity in Patients with Glomerulonephritis

Journal of the American Society of Nephrology ◽

10.1097/01.asn.0000092789.67966.5c ◽

2003 ◽

Vol 14 (11) ◽

pp. 2861-2872 ◽

Cited By ~ 31

Author(s):

N. Lods

Keyword(s):

Angiotensin Ii ◽

Matrix Metalloproteinase ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Blockade ◽

Metalloproteinase Activity